Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3).


Journal

Neuroendocrinology
ISSN: 1423-0194
Titre abrégé: Neuroendocrinology
Pays: Switzerland
ID NLM: 0035665

Informations de publication

Date de publication:
2019
Historique:
received: 26 06 2018
accepted: 27 08 2018
pubmed: 29 8 2018
medline: 18 12 2019
entrez: 29 8 2018
Statut: ppublish

Résumé

Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) are classified based on morphology and graded based on their proliferation rate as either well-differentiated low-grade (G1 to G2) neuroendocrine tumors (NET) or poorly differentiated high-grade (G3) neuroendocrine carcinomas (NEC). Recently, a new subgroup of well-differentiated high-grade pancreatic tumors (NET G3) has been defined. The GEP NEN G3 group consisting of both NEC and NET G3 has recently been shown to be a quite heterogeneous patient group concerning prognosis and treatment benefit, depending on factors such as the primary tumor site, differentiation, proliferation rate, and molecular alterations. In this review we discuss the existing data on diagnostics, treatment, and biomarkers in this patient group, the unmet needs, and the future perspectives.

Identifiants

pubmed: 30153658
pii: 000493318
doi: 10.1159/000493318
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

54-62

Investigateurs

Detlef Bartsch (D)
Rudolf Arnold (R)
Eric Baudin (E)
Lisa Bodei (L)
Ivan Borbath (I)
Jaume Capdevila (J)
Martyn Caplin (M)
Jie Chen (J)
Frederico Costa (F)
Anne Couvelard (A)
Jaroslaw Ćwikła (J)
Philippa Davies (P)
Herder de (H)
Massimo Falconi (M)
Jenny Falkerby (J)
Nicola Fazio (N)
Diego Ferone (D)
Andrea Frilling (A)
Rocio Garcia-Carbonero (R)
Simona Glasberg (S)
Vera Gorbunova (V)
Ashley Grossman (A)
Dieter Hörsch (D)
Robert Jensen (R)
Gregory Kaltsas (G)
Günter Klöppel (G)
Ulrich Knigge (U)
Beata Kos-Kudła (B)
Guenter Krejs (G)
Eric Krenning (E)
Matthew Kulke (M)
Steven Lamberts (S)
van Nieveen (V)
Juan O'Connor (J)
Dermot O'Toole (D)
Ulrich-Frank Pape (UF)
Stefano Partelli (S)
Marianne Pavel (M)
Marc Peeters (M)
John Ramage (J)
Nicholas Reed (N)
Guido Rindi (G)
Anja Rinke (A)
Philippe Ruszniewski (P)
Halfdan Sorbye (H)
Anders Sundin (A)
Jean-Yves Scoazec (JY)
Babs Taal (B)
Janson Tiensuu (J)
Christos Toumpanakis (C)
Juan Valle (J)
Marie-Pierre Vullierme (MP)
Staffan Welin (S)
Bertram Wiedenmann (B)

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Halfdan Sorbye (H)

Department of Oncology and Clinical Science, Haukeland University Hospital, Bergen, Norwayhalfdan.sorbye@helse-bergen.no.

Eric Baudin (E)

Endocrine Oncology, Gustave Roussy, Villejuif, France.

Ivan Borbath (I)

Hepato-Gastroenterology Unit, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.

Martyn Caplin (M)

Neuroendocrine Tumour Unit, Centre for Gastroenterology, Royal Free Hospital, London, United Kingdom.

Jie Chen (J)

Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

Jaroslaw B Cwikla (JB)

Faculty of Medical Sciences, University of Warmia and Mazury, Olsztyn, Poland.

Andrea Frilling (A)

Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Ashley Grossman (A)

Neuroendocrine Tumour Unit, Royal Free Hospital, London, United Kingdom.

Gregory Kaltsas (G)

National and Kapodistrian University of Athens, Athens, Greece.

Aldo Scarpa (A)

ARC-Net Centre for Applied Research on Cancer and Section of Pathology of the Department of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.

Staffan Welin (S)

Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden.

Rocio Garcia-Carbonero (R)

Oncology Department, Hospital Universitario 12 de Octubre, CNIO, CIBERONC, Universidad Complutense de Madrid, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH